Will VIR-5818 enter Phase 2 trials by end of 2025? | Binary | | | 1 day ago | |
Will VIR-5818 achieve an ORR of 50%+ in HER2 cancers by end of 2025? | Binary | | | 1 day ago | |
Will maximum tolerated dose be determined for VIR-5818 and VIR-5500 by end of 2025? | Categorical | | | 1 day ago | |
How does VIR-5818's ORR in HER2 cancers compare to Enhertu by end of 2025? | Categorical | | | 1 day ago | |
Will VIR-5500 achieve a PSA50 response rate of 70%+ in mCRPC by mid-2025? | Binary | | | 1 day ago | |
Will Vir begin a Phase 3 trial for VIR-5818 or VIR-5500 by end of 2025? | Binary | | | 1 day ago | |
Vir Biotechnology stock price change by end of Q1 2025? | Categorical | | | 1 day ago | |
Will VIR-5818 or VIR-5500 get FDA Fast Track by end of 2025? | Categorical | | | 1 day ago | |
What will be the PSA response outcome of VIR-5500 Phase 1 trial in mCRPC by end of 2025? | Categorical | | | 1 day ago | |
What will be the outcome of VIR-5818 Phase 1 trial in HER2-positive CRC by end of 2025? | Categorical | | | 1 day ago | |
Will VIR-5500 enter Phase 2 trials by end of 2025? | Binary | | | 1 day ago | |
Will Vir Biotechnology report no Grade 3 CRS for VIR-5818 and VIR-5500 by end of 2025? | Binary | | | 1 day ago | |
